← SynDRA
DUVELISIB
SynDRA canonical compound SYN0037749 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx |
|---|
| Primary target(s) | PIK3CG |
|---|
| Mechanism of action | PI3K inhibitor |
|---|
All known targets
- PIK3CD
- PIK3CG
- PIK3CA
- PIK3CB
Mechanisms of action (all sources)
- PI3K inhibitor
- PIK3CD INHIBITOR
- PI3-kinase p110-delta subunit inhibitor
- PIK3CG INHIBITOR
- PI3-kinase p110-gamma subunit inhibitor
- PIK3CD MODULATOR
- PIK3CG MODULATOR
ATC classes
- L01E · PROTEIN KINASE INHIBITORS
Cross-references
Synonyms
- copiktra
- IPI-145
- INK-1197
- ABBV-954
- INK-1147
- UNII-610V23S0JI;
- IPI 145
- duvelisibum
- RefChem:57412
- DTXCID2075188
- Duvelisib (IPI-145, INK1197)
- MFCD15144635
- C22H17ClN6O
- IPI145
- Duvelisib [USAN]
- UNII-610V23S0JI
- Duvelisib [USAN:INN]
- Duvelisib (IPI-145)
- IPI-145 (INK1197)
- IPI-145;INK1197
- INK1197
- Duvelisib Impurity 1
- DUVELISIB [INN]
- DUVELISIB [MI]
- Duvelisib (USAN/INN)
- DUVELISIB [WHO-DD]
- SCHEMBL153543
- GTPL7795
- NIR178
- orb1306832
- DUVELISIB [ORANGE BOOK]
- SCHEMBL18343557
- SCHEMBL19670020
- SCHEMBL20580104
- SCHEMBL29350979
- SCHEMBL29360900
- SCHEMBL29535385
- SCHEMBL29538168
Reported adverse events
- P
- Abdominal pain
- Arthralgia
- Colitis
- Constipation
- Cough
- Fatigue
- Headache
- Infection
- Lipase increased
- Lower respiratory tract infection
- Musculoskeletal pain
Look up DUVELISIB in the interactive SynDRA portal →